유전체학 시장 규모, 점유율 및 동향 분석 보고서 : 용도별, 성과물별, 최종 용도별, 지역별, 부문 예측(2026-2033년)

Genomics Market Size, Share & Trends Analysis Report By Application (Functional Genomics, Epigenomics, Pathway Analysis, Biomarker Discovery), By Deliverables (Products, Services), By End-use, By Region, And Segment Forecasts, 2026 - 2033

US $ 5,950 ￦ 8,888,000

Unprintable PDF & Excel (Single User License)

보고서 PDF 및 엑셀을 1인만 사용할 수 있는 라이선스입니다. 텍스트 등의 복사 및 붙여넣기, 인쇄는 불가능합니다.

US $ 6,950 ￦ 10,381,000

Printable PDF & Excel (5-User License)

보고서 PDF 및 엑셀을 동일 기업 내 동일 부서에서 최대 5명까지 사용할 수 있는 라이선스입니다. 텍스트 등의 복사 및 붙여넣기, 인쇄는 가능합니다.

US $ 8,950 ￦ 13,369,000

Printable PDF & Excel (Enterprise License)

PDF & Excel 보고서를 동일 기업(자회사 포함)의 모든 분이 이용할 수 있는 라이선스입니다. 텍스트 등의 복사 및 붙여넣기, 인쇄는 가능합니다. 인쇄물의 이용 범위는 파일의 이용 범위와 동일합니다.

한글목차

유전체학 시장 개요

세계의 유전체학 시장 규모는 2025년 217억 6,000만 달러로 추정되며, 2033년에 725억 달러에 이를 것으로 예측됩니다.

또한 2026-2033년에는 CAGR 18.2%를 나타낼 것으로 예측됩니다. 이러한 성장은 헬스케어, 산업 생명공학, 연구 분야에서 첨단 유전자 설계, 채널 엔지니어링, 데이터 기반 생물학적 혁신을 가능하게 하는 새로운 유전체학 응용기술에 의해 뒷받침되고 있습니다.

목차

제1장 조사 방법과 범위

제2장 주요 요약

제3장 시장 변수, 동향, 범위

제4장 용도별 비즈니스 분석

제5장 성과물 별 비즈니스 분석

제6장 최종 용도별 비즈니스 분석

제7장 지역별 비즈니스 분석

제8장 경쟁 구도

LSH

영문 목차

영문목차

Genomics Market Summary

The global genomics market size was estimated at USD 21.76 billion in 2025 and is projected to reach USD 72.50 billion by 2033, growing at a CAGR of 18.2% from 2026 to 2033. This growth is supported by emerging genomics applications, which enable advanced genetic design, pathway engineering, and data-driven biological innovation across healthcare, industrial biotechnology, and research applications.

Global Genomics Market Report Segmentation

This report forecasts revenue growth and provides an analysis of the latest trends in each of the sub-segments from 2021 to 2033. For this report, Grand View Research has segmented the global genomics market report based on application, deliverables, end-use, and region.

• Application Outlook (Revenue, USD Million, 2021 - 2033)
• Functional Genomics
  • Real-time PCR
  • Transfection
  • SNP Analysis
  • Mutational Analysis
  • Microarray Analysis
  • RNA Interference
• Epigenomics
  • Bisulfite Sequencing
  • Microarray Analysis
  • Chromatin Immunoprecipitation (ChIP & ChIP-Seq)
  • Methylated DNA Immunoprecipitation (MeDIP)
  • High Resolution Melt (HRM)
  • Chromatin Accessibility Assays
• Pathway Analysis
  • Microarray Analysis
  • Bead-based Analysis
  • Proteomics Tools (2-D PAGE; yeast 2-hybrid studies)
  • Real-time PCR
• Biomarker Discovery
  • DNA Sequencing
  • Microarray Analysis
  • Real-time PCR
  • Mass Spectrometry
  • Statistical Analysis
  • Bioinformatics
• Others
• Deliverables Outlook (Revenue, USD Million, 2021 - 2033)
• Products
  • Instruments/Systems/Software
  • Consumables & Reagents
• Services
  • NGS-based Services
  • Core Genomics Services
  • Biomarker Translation Services
  • Computational Services
  • Others
• End-use Outlook (Revenue, USD Million, 2021 - 2033)
• Pharmaceutical and Biotechnology Companies
• Hospitals and Clinics
• Academic and Government Institutes
• Clinical Research
• Other End Users
• Regional Outlook (Revenue, USD Million, 2021 - 2033)
• North America
  • U.S.
  • Canada
  • Mexico
• Europe
  • UK
  • Germany
  • France
  • Italy
  • Spain
  • Denmark
  • Sweden
  • Norway
• Asia Pacific
  • Japan
  • China
  • India
  • South Korea
  • Australia
  • Thailand
• Latin America
  • Brazil
  • Argentina
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Kuwaita

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation & Scope
• 1.2. Market Definitions
  • 1.2.1. Application Segment
  • 1.2.2. Deliverables Segment
  • 1.2.3. End Use Segment
• 1.3. Information Analysis
  • 1.3.1. Market Formulation & Data Visualization
• 1.4. Data Validation & Publishing
• 1.5. Information Procurement
  • 1.5.1. Primary Research
• 1.6. Information or Data Analysis
• 1.7. Market Formulation & Validation
• 1.8. Market Model
• 1.9. Objectives

Chapter 2. Executive Summary

• 2.1. Market Outlook
• 2.2. Segment Snapshot
• 2.3. Competitive Landscape Snapshot

Chapter 3. Market Variables, Trends, & Scope

• 3.1. Market Lineage Outlook
  • 3.1.1. Parent Market Outlook
  • 3.1.2. Related/Ancillary Market Outlook
• 3.2. Market Trends and Outlook
• 3.3. Market Dynamics
  • 3.3.1. Rapid Technological Advancements
  • 3.3.2. Precision Medicine & Personalized Healthcare
• 3.4. Market Restraint Analysis
  • 3.4.1. High Cost of Genomics Technologies
• 3.5. Industry Analysis Tools
  • 3.5.1. PESTLE Analysis
  • 3.5.2. Porter's Five Forces Analysis

Chapter 4. Application Business Analysis

• 4.1. Application Segment Dashboard
• 4.2. Global Genomics Market: Application Movement Analysis
• 4.3. Global Genomics Market Size & Trend Analysis, by Application, 2021 to 2033 (USD Million)
• 4.4. Functional Genomics
  • 4.4.1. Functional Genomics Market, 2021 - 2033 (USD Million)
  • 4.4.2. Real-time PCR
    • 4.4.2.1. Real-time PCR Market, 2021 - 2033 (USD Million)
  • 4.4.3. Transfection
    • 4.4.3.1. Transfection Market, 2021 - 2033 (USD Million)
  • 4.4.4. SNP Analysis
    • 4.4.4.1. SNP Analysis Market, 2021 - 2033 (USD Million)
  • 4.4.5. Mutational Analysis
    • 4.4.5.1. Mutational Analysis Market, 2021 - 2033 (USD Million)
  • 4.4.6. Microarray Analysis
    • 4.4.6.1. Microarray Analysis Market, 2021 - 2033 (USD Million)
  • 4.4.7. RNA Interference
    • 4.4.7.1. RNA Interference Market, 2021 - 2033 (USD Million)
• 4.5. Epigenomics
  • 4.5.1. Epigenomics Market, 2021 - 2033 (USD Million)
  • 4.5.2. Bisulfite Sequencing
    • 4.5.2.1. Bisulfite Sequencing Market, 2021 - 2033 (USD Million)
  • 4.5.3. Microarray Analysis
    • 4.5.3.1. Microarray Analysis Market, 2021 - 2033 (USD Million)
  • 4.5.4. Chromatin Immunoprecipitation (ChIP & ChIP-Seq)
    • 4.5.4.1. Chromatin Immunoprecipitation (ChIP & ChIP-Seq) Market, 2021 - 2033 (USD Million)
  • 4.5.5. Methylated DNA Immunoprecipitation (MeDIP)
    • 4.5.5.1. Methylated DNA Immunoprecipitation (MeDIP) Market, 2021 - 2033 (USD Million)
  • 4.5.6. High Resolution Melt (HRM)
    • 4.5.6.1. High Resolution Melt (HRM) Market, 2021 - 2033 (USD Million)
  • 4.5.7. Chromatin Accessibility Assays
    • 4.5.7.1. Chromatin Accessibility Assays Market, 2021 - 2033 (USD Million)
• 4.6. Pathway Analysis
  • 4.6.1. Pathway Analysis Market, 2021 - 2033 (USD Million)
  • 4.6.2. Microarray Analysis
    • 4.6.2.1. Microarray Analysis Market, 2021 - 2033 (USD Million)
  • 4.6.3. Bead-based Analysis
    • 4.6.3.1. Bead-based Analysis Market, 2021 - 2033 (USD Million)
  • 4.6.4. Proteomics Tools (2-D PAGE; yeast 2-hybrid studies)
    • 4.6.4.1. Proteomics Tools (2-D PAGE; yeast 2-hybrid studies) Market, 2021 - 2033 (USD Million)
  • 4.6.5. Real-time PCR
    • 4.6.5.1. Real-time PCR Market, 2021 - 2033 (USD Million)
• 4.7. Biomarker Discovery
  • 4.7.1. Biomarker Discovery Market, 2021 - 2033 (USD Million)
  • 4.7.2. DNA Sequencing
    • 4.7.2.1. DNA Sequencing Market, 2021 - 2033 (USD Million)
  • 4.7.3. Microarray Analysis
    • 4.7.3.1. Microarray Analysis Market, 2021 - 2033 (USD Million)
  • 4.7.4. Real-time PCR
    • 4.7.4.1. Real-time PCR Market, 2021 - 2033 (USD Million)
  • 4.7.5. Mass Spectrometry
    • 4.7.5.1. Mass Spectrometry Market, 2021 - 2033 (USD Million)
  • 4.7.6. Statistical Analysis
    • 4.7.6.1. Statistical Analysis Market, 2021 - 2033 (USD Million)
  • 4.7.7. Bioinformatics
    • 4.7.7.1. Bioinformatics Market, 2021 - 2033 (USD Million)
• 4.8. Others
  • 4.8.1. Others Market, 2021 - 2033 (USD Million)

Chapter 5. Deliverables Business Analysis

• 5.1. Deliverables Segment Dashboard
• 5.2. Global Genomics Market: Deliverables Movement Analysis
• 5.3. Global Genomics Market Size & Trend Analysis, by Deliverables, 2021 to 2033 (USD Million)
• 5.4. Products
  • 5.4.1. Products Market, 2021 - 2033 (USD Million)
  • 5.4.2. Instruments/Systems/Software
    • 5.4.2.1. Instruments/Systems/Software Market, 2021 - 2033 (USD Million)
  • 5.4.3. Consumables & Reagents
    • 5.4.3.1. Consumables & Reagents Market, 2021 - 2033 (USD Million)
• 5.5. Services
  • 5.5.1. Services Market, 2021 - 2033 (USD Million)
  • 5.5.2. NGS-based Services
    • 5.5.2.1. NGS-based Services Market, 2021 - 2033 (USD Million)
  • 5.5.3. Core Genomics Services
    • 5.5.3.1. Core Genomics Services Market, 2021 - 2033 (USD Million)
  • 5.5.4. Biomarker Translation Services
    • 5.5.4.1. Biomarker Translation Services Market, 2021 - 2033 (USD Million)
  • 5.5.5. Computational Services
    • 5.5.5.1. Computational Services Market, 2021 - 2033 (USD Million)
  • 5.5.6. Others
    • 5.5.6.1. Others Market, 2021 - 2033 (USD Million)

Chapter 6. End Use Business Analysis

• 6.1. End Use Segment Dashboard
• 6.2. Global Genomics Market: End Use Movement Analysis
• 6.3. Global Genomics Market Size & Trend Analysis, by End Use, 2021 to 2033 (USD Million)
• 6.4. Pharmaceutical and Biotechnology Companies
  • 6.4.1. Pharmaceutical and Biotechnology Companies Market, 2021 - 2033 (USD Million)
• 6.5. Hospitals and Clinics
  • 6.5.1. Hospitals and Clinics Market, 2021 - 2033 (USD Million)
• 6.6. Academic and Government Institutes
  • 6.6.1. Academic and Government Institutes Market, 2021 - 2033 (USD Million)
• 6.7. Clinical Research
  • 6.7.1. Clinical Research Market, 2021 - 2033 (USD Million)
• 6.8. Others
  • 6.8.1. Others Market, 2021 - 2033 (USD Million)

Chapter 7. Regional Business Analysis

• 7.1. Regional Dashboard
• 7.2. Market Size & Forecasts and Trend Analysis, 2021 to 2033
• 7.3. North America
  • 7.3.1. North America Genomics Market, 2021 - 2033 (USD Million)
  • 7.3.2. U.S.
    • 7.3.2.1. Key Country Dynamics
    • 7.3.2.2. Competitive Scenario
    • 7.3.2.3. Regulatory Framework
    • 7.3.2.4. U.S. Genomics Market, 2021 - 2033 (USD MILLION)
  • 7.3.3. Canada
    • 7.3.3.1. Key Country Dynamics
    • 7.3.3.2. Competitive Scenario
    • 7.3.3.3. Regulatory Framework
    • 7.3.3.4. Canada Genomics Market, 2021 - 2033 (USD Million)
  • 7.3.4. Mexico
    • 7.3.4.1. Key Country Dynamics
    • 7.3.4.2. Competitive Scenario
    • 7.3.4.3. Regulatory Framework
    • 7.3.4.4. Mexico Genomics Market, 2021 - 2033 (USD Million)
• 7.4. Europe
  • 7.4.1. Europe Genomics Market, 2021 - 2033 (USD Million)
  • 7.4.2. Germany
    • 7.4.2.1. Key Country Dynamics
    • 7.4.2.2. Competitive Scenario
    • 7.4.2.3. Regulatory Framework
    • 7.4.2.4. Germany Genomics Market, 2021 - 2033 (USD Million)
  • 7.4.3. UK
    • 7.4.3.1. Key Country Dynamics
    • 7.4.3.2. Competitive Scenario
    • 7.4.3.3. Regulatory Framework
    • 7.4.3.4. UK Genomics Market, 2021 - 2033 (USD Million)
  • 7.4.4. France
    • 7.4.4.1. Key Country Dynamics
    • 7.4.4.2. Competitive Scenario
    • 7.4.4.3. Regulatory Framework
    • 7.4.4.4. France Genomics Market, 2021 - 2033 (USD Million)
  • 7.4.5. Italy
    • 7.4.5.1. Key Country Dynamics
    • 7.4.5.2. Competitive Scenario
    • 7.4.5.3. Regulatory Framework
    • 7.4.5.4. Italy Genomics Market, 2021 - 2033 (USD Million)
  • 7.4.6. Spain
    • 7.4.6.1. Key Country Dynamics
    • 7.4.6.2. Competitive Scenario
    • 7.4.6.3. Regulatory Framework
    • 7.4.6.4. Spain Genomics Market, 2021 - 2033 (USD Million)
  • 7.4.7. Denmark
    • 7.4.7.1. Key Country Dynamics
    • 7.4.7.2. Competitive Scenario
    • 7.4.7.3. Regulatory Framework
    • 7.4.7.4. Denmark Genomics Market, 2021 - 2033 (USD Million)
  • 7.4.8. Sweden
    • 7.4.8.1. Key Country Dynamics
    • 7.4.8.2. Competitive Scenario
    • 7.4.8.3. Regulatory Framework
    • 7.4.8.4. Sweden Genomics Market, 2021 - 2033 (USD Million)
  • 7.4.9. Norway
    • 7.4.9.1. Key Country Dynamics
    • 7.4.9.2. Competitive Scenario
    • 7.4.9.3. Regulatory Framework
    • 7.4.9.4. Norway Genomics Market, 2021 - 2033 (USD Million)
• 7.5. Asia Pacific
  • 7.5.1. Asia Pacific Genomics Market, 2021 - 2033 (USD Million)
  • 7.5.2. Japan
    • 7.5.2.1. Key Country Dynamics
    • 7.5.2.2. Competitive Scenario
    • 7.5.2.3. Regulatory Framework
    • 7.5.2.4. Japan Genomics Market, 2021 - 2033 (USD Million)
  • 7.5.3. China
    • 7.5.3.1. Key Country Dynamics
    • 7.5.3.2. Competitive Scenario
    • 7.5.3.3. Regulatory Framework
    • 7.5.3.4. China Genomics Market, 2021 - 2033 (USD Million)
  • 7.5.4. India
    • 7.5.4.1. Key Country Dynamics
    • 7.5.4.2. Competitive Scenario
    • 7.5.4.3. Regulatory Framework
    • 7.5.4.4. India Genomics Market, 2021 - 2033 (USD Million)
  • 7.5.5. South Korea
    • 7.5.5.1. Key Country Dynamics
    • 7.5.5.2. Competitive Scenario
    • 7.5.5.3. Regulatory Framework
    • 7.5.5.4. South Korea Genomics Market, 2021 - 2033 (USD Million)
  • 7.5.6. Australia
    • 7.5.6.1. Key Country Dynamics
    • 7.5.6.2. Competitive Scenario
    • 7.5.6.3. Regulatory Framework
    • 7.5.6.4. Australia Genomics Market, 2021 - 2033 (USD Million)
  • 7.5.7. Thailand
    • 7.5.7.1. Key Country Dynamics
    • 7.5.7.2. Competitive Scenario
    • 7.5.7.3. Regulatory Framework
    • 7.5.7.4. Thailand Genomics Market, 2021 - 2033 (USD Million)
• 7.6. Latin America
  • 7.6.1. Latin America Genomics Market, 2021 - 2033 (USD Million)
  • 7.6.2. Brazil
    • 7.6.2.1. Key Country Dynamics
    • 7.6.2.2. Competitive Scenario
    • 7.6.2.3. Regulatory Framework
    • 7.6.2.4. Brazil Genomics Market, 2021 - 2033 (USD Million)
  • 7.6.3. Argentina
    • 7.6.3.1. Key Country Dynamics
    • 7.6.3.2. Competitive Scenario
    • 7.6.3.3. Regulatory Framework
    • 7.6.3.4. Argentina Genomics Market, 2021 - 2033 (USD Million)
• 7.7. MEA
  • 7.7.1. MEA Genomics Market, 2021 - 2033 (USD Million)
  • 7.7.2. South Africa
    • 7.7.2.1. Key Country Dynamics
    • 7.7.2.2. Competitive Scenario
    • 7.7.2.3. Regulatory Framework
    • 7.7.2.4. South Africa Genomics Market, 2021 - 2033 (USD Million)
  • 7.7.3. Saudi Arabia
    • 7.7.3.1. Key Country Dynamics
    • 7.7.3.2. Competitive Scenario
    • 7.7.3.3. Regulatory Framework
    • 7.7.3.4. Saudi Arabia Genomics Market, 2021 - 2033 (USD Million)
  • 7.7.4. UAE
    • 7.7.4.1. Key Country Dynamics
    • 7.7.4.2. Competitive Scenario
    • 7.7.4.3. Regulatory Framework
    • 7.7.4.4. UAE Genomics Market, 2021 - 2033 (USD Million)
  • 7.7.5. Kuwait
    • 7.7.5.1. Key Country Dynamics
    • 7.7.5.2. Competitive Scenario
    • 7.7.5.3. Regulatory Framework
    • 7.7.5.4. Kuwait Genomics Market, 2021 - 2033 (USD Million)

Chapter 8. Competitive Landscape

• 8.1. Participant Categorization
• 8.2. Strategy Mapping
• 8.3. Company Market Position Analysis, 2025
• 8.4. Participant's Overview
  • 8.4.1. Illumina, Inc.
    • 8.4.1.1. Overview
    • 8.4.1.2. Financial Performance
    • 8.4.1.3. Product Benchmarking
    • 8.4.1.4. Strategic Initiatives
  • 8.4.2. Thermo Fisher Scientific, Inc.
    • 8.4.2.1. Overview
    • 8.4.2.2. Financial Performance
    • 8.4.2.3. Product Benchmarking
    • 8.4.2.4. Strategic Initiatives
  • 8.4.3. Danaher Corporation
    • 8.4.3.1. Overview
    • 8.4.3.2. Financial Performance
    • 8.4.3.3. Product Benchmarking
    • 8.4.3.4. Strategic Initiatives
  • 8.4.4. F. Hoffmann-La Roche Ltd.
    • 8.4.4.1. Overview
    • 8.4.4.2. Financial Performance
    • 8.4.4.3. Product Benchmarking
    • 8.4.4.4. Strategic Initiatives
  • 8.4.5. Agilent Technologies
    • 8.4.5.1. Overview
    • 8.4.5.2. Financial Performance
    • 8.4.5.3. Product Benchmarking
    • 8.4.5.4. Strategic Initiatives
  • 8.4.6. BGI Genomics
    • 8.4.6.1. Overview
    • 8.4.6.2. Financial Performance
    • 8.4.6.3. Product Benchmarking
    • 8.4.6.4. Strategic Initiatives
  • 8.4.7. QIAGEN N.V.
    • 8.4.7.1. Overview
    • 8.4.7.2. Financial Performance
    • 8.4.7.3. Product Benchmarking
    • 8.4.7.4. Strategic Initiatives
  • 8.4.8. Oxford Nanopore Technologies
    • 8.4.8.1. Overview
    • 8.4.8.2. Financial Performance
    • 8.4.8.3. Product Benchmarking
    • 8.4.8.4. Strategic Initiatives
  • 8.4.9. PacBio.
    • 8.4.9.1. Overview
    • 8.4.9.2. Financial Performance
    • 8.4.9.3. Product Benchmarking
    • 8.4.9.4. Strategic Initiatives
  • 8.4.10. Bio-Rad Laboratories, Inc.
    • 8.4.10.1. Overview
    • 8.4.10.2. Financial Performance
    • 8.4.10.3. Product Benchmarking
    • 8.4.10.4. Strategic Initiatives

관련자료